Howard Mayer - Shire Plc President

President

Dr. Howard Mayer, M.D., was appointed as Chief Medical Officer of the Company, with effective from January 2018. Howard Mayer, MD, is currently Senior Vice President and Head of RD at Shire. Previously, he was Senior Vice President and Head of Global Clinical Development at the Company. Dr. Mayer joined Shire in 2012 and was responsible for global clinical development across immunology, hereditary angioedema, hematology, lysosomal storage disorders, gastrointestinal internal medicine endocrine, ophthalmics, a growing franchise in oncology, and neuroscience. Prior to joining Shire, he served as Chief Medical Officer at EMD Serono, a division of Merck KGaA since 2018.
Tenure 6 years
Phone(353) 1 609 6000
Webwww.shire.com
Mayer obtained his BA from the University of Pennsylvania and his MD from Albert Einstein College of Medicine in New York, which was followed by an internship and residency at Mount Sinai Hospital and an Infectious Diseases fellowship at Harvard Medical School. He currently serves on the Board of Directors for Genocea Biosciences, as well as the scientific advisory boards of Macrolide Pharmaceuticals and Arsanis Biosciences.

Shire Plc Management Efficiency

Shire Plc's management efficiency ratios could be used to measure how well Shire Plc manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 15.35 B in liabilities with Debt to Equity (D/E) ratio of 41.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Shire Plc has a current ratio of 0.9, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Shire Plc until it has trouble settling it off, either with new capital or with free cash flow. So, Shire Plc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Shire Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Shire to invest in growth at high rates of return. When we think about Shire Plc's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

William StaxAsbury Automotive Group
48
Michael OConnorAspen Aerogels
N/A
George VillasanaAsbury Automotive Group
56
Liana GelikasSapiens International
N/A
H GoforthGMS Inc
51
George KarolisAsbury Automotive Group
42
Leslie KratcoskiGMS Inc
N/A
Douglas GoforthGMS Inc
52
Hui LiangNetSol Technologies
N/A
Howard GoforthGMS Inc
54
Corby WhitakerAspen Aerogels
54
John FairbanksAspen Aerogels
63
George GouldAspen Aerogels
56
Sean GoodmanAsbury Automotive Group
53
Gregg LandesAspen Aerogels
53
Patrick GuidoAsbury Automotive Group
47
Jed MilsteinAsbury Automotive Group
55
John HartmanAsbury Automotive Group
55
Scott PalmerSapiens International
N/A
Craig ApolinskyGMS Inc
57
Kelley ConteAspen Aerogels
59
Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company was founded in 1986 and is headquartered in Dublin, Ireland. Shire plc operates under Biotechnology classification in USA and is traded on NASDAQ. It employs 23044 people. Shire Plc (SHPG) is traded on NASDAQ Exchange in USA and employs 23,044 people.

Management Performance

Shire Plc Leadership Team

Elected by the shareholders, the Shire Plc's board of directors comprises two types of representatives: Shire Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shire. The board's role is to monitor Shire Plc's management team and ensure that shareholders' interests are well served. Shire Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shire Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sara Mathew, Non-Executive Director
Perry Sternberg, Head - U.S. Commercial
Ian Clark, Non-Executive Director
Christoph Brackmann, Interim Head of Investor Relations
William Mordan, General Counsel and Corporate Secretary
Gisele Dion, Chief Accounting Officer, Corporate Controller
Flemming Ornskov, CEO, Director
Bill Mordan, General Counsel, Company Secretary
Gail Fosler, Non-Executive Director
Philip Vickers, Head - Research and Development
David Ginsburg, Non-Executive Independent Director
Joanne Cordeiro, Chief Human Resource Officer
Jeffrey Poulton, CFO and Director
Matthew Walker, Head - Technical Operations
Ian Karp, Head of Investor Relations
Olivier Bohuon, Non-Executive Director
Susan Kilsby, Non-Executive Chairman of the Board
John Miller, Interim CFO
Andreas Busch, Executive Vice President - Head of Research and Development, Chief Scientific Officer
Howard Mayer, Senior Vice President -Head of Research and Development
Phil Vickers, Head of Research and Development
Albert Stroucken, Non-Executive Director
William Burns, Non-Executive Independent Director
Dominic Blakemore, Non-Executive Director
Oliver Strawbridge, Senior Assistant Company Secretary
Ginger Gregory, Chief Human Resource Officer
Steven Gillis, Non-Executive Independent Director
Kim Stratton, Head - International Commercial
David Kappler, Senior Independent Non-Executive Deputy Chairman of the Board
Thomas Dittrich, CFO, Executive Director
Anne Minto, Non-Executive Independent Director
Mark Enyedy, Head of Corporate Devel. and Interim General Counsel

Shire Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shire Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Shire Plc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Shire Plc's short interest history, or implied volatility extrapolated from Shire Plc options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Shire Stock

If you are still planning to invest in Shire Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shire Plc's history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges